All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

@juulianbecerra's brain peptide stack claims, fact-checked

Julian Becerra

TikTok creator

289.0K viewsWatch on TikTok→

Quick answer

Semax and selank are synthetic neuropeptides with preliminary evidence for anxiolytic and nootropic effects, drawn primarily from Russian preclinical and small clinical studies, with no large-scale, independently replicated human trials confirming cognitive enhancement in healthy adults. The creator's reported experience, smoother word retrieval and faster task completion without stimulant side effects, is pharmacologically plausible but entirely anecdotal and confounded by multiple uncontrolled variables. Neither compound is FDA-approved, and long-term safety data in humans remains limited.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @juulianbecerra actually say?

The creator filmed himself taking two peptides, semax and selank, then timed how long it took to write and film a YouTube video. His baseline was three and a half hours. After dosing, he finished in one hour and thirty-seven minutes. He described "memory recall and sentence formation" flowing smoother, but pointedly said he did not feel stimulated the way caffeine or Adderall makes him feel. He framed semax as something that "flips on the focus and motivation switch" and selank as killing "mental noise" like an anti-anxiety compound. He claimed the two together create a "synergistic effect." The self-experiment framing is honest in one sense: he never pretended this was a clinical trial. But it also means his conclusions rest entirely on one data point, his own experience, during one task, on one day, with no control condition.

Does the science back this up?

Partially, but the evidence base is thin and almost entirely from Russian research institutions with no independent replication in Western peer-reviewed literature. Semax is a synthetic analog of ACTH(4-7), originally developed in Russia in the 1980s. Animal studies show it increases BDNF and dopaminergic activity in the prefrontal cortex. Selank is a synthetic analog of tuftsin with anxiolytic properties studied in Russian clinical settings.

  • Semax has shown cognitive-enhancing effects in rat models of stroke and ischemia (Bobyntsev et al., 2015, Neuropeptides), but healthy human cognition data is scarce.
  • Selank demonstrated anxiolytic effects comparable to phenazepam in small Russian clinical trials (Semenova et al., 2010, Bulletin of Experimental Biology and Medicine), without sedation, which aligns with the creator's "no feel" observation.
  • The "synergy" claim has no published pharmacokinetic or pharmacodynamic data supporting it in humans. That does not mean it is false, it means nobody has tested it rigorously.

Extrapolating rodent neuropeptide studies to a healthy 20-something's YouTube workflow is a significant leap.

What did they get wrong (or right)?

He got the mechanisms roughly right, but oversimplified them in ways that matter. Calling semax something that "speeds up how fast you process and recall info" treats a theoretical BDNF-upregulation mechanism as a proven, direct cognitive output. That is not what the studies show, especially not in healthy subjects.

He also got something meaningfully right: his observation that the compounds did not produce a stimulant feeling is consistent with selank's pharmacology. Unlike benzodiazepines, selank modulates GABAergic transmission without the sedation or dependency signals, and unlike amphetamines, semax does not directly release catecholamines. His subjective experience is plausible given the pharmacology, even if we cannot confirm it caused his faster output.

What he got wrong: the self-experiment design is so confounded it proves nothing. Variables include time of day, task familiarity, motivation to perform on camera, and simple practice effects. Cutting a task time in half once is not evidence that a compound works. It is an anecdote with a timer.

What should you actually know?

Semax and selank are not FDA-approved for any indication in the United States. They are not scheduled controlled substances, which puts them in a legal gray area. Several compounding pharmacies sell them, but quality control, purity, and dosing consistency vary considerably with no mandatory testing standards applied uniformly across suppliers.

The absence of a stimulant feeling is not proof of safety. Both peptides act on neuropeptide systems that are not well-characterized in long-term human use. Selank's GABAergic activity means dependency questions are not fully answered. Semax influences BDNF, which has complex roles in mood, anxiety, and even tumor biology in some animal models.

Anyone considering these compounds should discuss them with a clinician who understands peptide pharmacology, not just replicate a TikTok timer experiment. The creator's experience is interesting as anecdote. It is not a reason to dose yourself.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @juulianbecerra's brain peptide stack claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@juulianbecerra's brain peptide stack claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

Semax and selank are synthetic neuropeptides with preliminary evidence for anxiolytic and nootropic effects, drawn primarily from Russian preclinical and small clinical studies, with no large-scale, independently replicated human trials confirming cognitive enhancement in healthy adults.

FormBlends verdict

Semax and selank are synthetic neuropeptides with preliminary evidence for anxiolytic and nootropic effects, drawn primarily from Russian preclinical and small clinical studies, with no large-scale, independently replicated human trials confirming cognitive enhancement in healthy adults. The creator's reported experience, smoother word retrieval and faster task completion without stimulant side effects, is pharmacologically plausible but entirely anecdotal and confounded by multiple uncontrolled variables. Neither compound is FDA-approved, and long-term safety data in humans remains limited.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semax and selank are synthetic neuropeptides with preliminary evidence for anxiolytic and nootropic effects, drawn primarily from Russian preclinical and small clinical studies, with no large-scale, independently replicated human trials confirming cognitive enhancement in healthy adults. The creator's reported experience, smoother word retrieval and faster task completion without stimulant side effects, is pharmacologically plausible but entirely anecdotal and confounded by multiple uncontrolled variables. Neither compound is FDA-approved, and long-term safety data in humans remains limited.
  • Semax is a synthetic ACTH analog with BDNF-upregulating effects shown in animal models, but controlled human trials in healthy adults are essentially absent from Western peer-reviewed literature.
  • Selank's anxiolytic effects have some clinical support from Russian trials (Semenova et al., 2010), but study sizes are small and independent replication is lacking.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Semax is a synthetic ACTH analog with BDNF-upregulating effects shown in animal models, but controlled human trials in healthy adults are essentially absent from Western peer-reviewed literature.
  • Selank's anxiolytic effects have some clinical support from Russian trials (Semenova et al., 2010), but study sizes are small and independent replication is lacking.
  • Neither semax nor selank is FDA-approved for any condition, placing them in a legal and regulatory gray area in the United States.
  • The creator's self-experiment had no control condition, no blinding, and no baseline correction for variables like task familiarity or performance motivation, making the timing result interesting but not meaningful as evidence.
  • The absence of stimulant-like side effects the creator described is pharmacologically plausible, but 'no obvious side effects in one session' is not the same as an established safety profile.
  • Long-term human safety data on semax and selank is limited, and selank's GABAergic activity means dependency and tolerance questions have not been conclusively answered.
  • Anyone considering these compounds should consult a clinician experienced in peptide pharmacology before use, not base decisions on a single TikTok timing experiment.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Julian Becerra · TikTok creator

289.0K views on this video

I tried the ultimate brain p*ptide stack… this is what I noticed

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Julian Becerra, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.